| Current reporting | Q1 | Q2 | Q3 | Q4 | Q5 | Q6 | Q7 | Q8 | Year End Following Q8 | ||
| 010 | 020 | 030 | 040 | 050 | 060 | 070 | 080 | 090 | 100 | ||
| MREL Items | 009 | ||||||||||
| Tier 2 capital | 010 | ||||||||||
| Tier 2 capital issued by subsidiaries | 020 | ||||||||||
| Tier 2 capital that is no longer eligible as regulatory capital due to prudential amortisations | 030 | ||||||||||
| Tier 2 capital issued by subsidiaries that is no longer eligible as regulatory capital due to prudential amortisations | 040 | ||||||||||
| MREL eligible subordinated unsecured liabilities | 050 | ||||||||||
| MREL eligible senior unsecured liabilities | 060 | ||||||||||
| Liabilities that are not MREL eligible | 070 | ||||||||||
| Total MREL eligible resources | 080 | ||||||||||
| Supplementary Information | 089 | ||||||||||
| Exposures to other MPE resolution groups that correspond to liabilities eligible for MREL (not applicable to SPE firms) | 090 | ||||||||||
| Investments in own non-regulatory capital MREL eligible liabilities | 100 | ||||||||||
| Reciprocal cross-holdings in non-regulatory capital MREL eligible liabilities | 110 | ||||||||||
| Investments in non-regulatory capital MREL eligible instruments of financial sector entities where the institution does not own more than 10% of the issued common share capital of the entity | 120 | ||||||||||
| Of which held in the trading book and will be sold within 30 business days | 130 | ||||||||||
| Investments in non-regulatory capital MREL eligible instruments of financial sector entities where the institution owns more than 10% of the issued common share capital of the entity | 140 | ||||||||||
| Ineligible CET1 | 150 | ||||||||||
| Ineligible AT1 | 160 | ||||||||||
| Ineligible T2 | 170 | ||||||||||